Grass Pollen Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2000

Grass pollen allergy is a reaction which occurs soon after exposure to pollen from grasses. Signs and symptoms include skin reactions, such as hives, redness or swelling, itching or tingling in or around the mouth and throat, tightening of the throat, shortness of breath or wheezing and runny nose. Predisposing factors include age, family history and other allergies.

The Grass pollen allergy – Drugs in Development research report provides a comprehensive overview on the therapeutics under development for Grass pollen allergy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.  The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.  Additionally, the report provides an overview of key players involved in therapeutic development for Grass pollen allergy and features dormant and discontinued projects.

Key Targets in the Grass Pollen Allergy Pipeline Drugs Market

The key targets in the Grass Pollen Allergy pipeline drugs market are Interleukin 4 Receptor Subunit Alpha, and Pituitary Adenylate Cyclase Activating Polypeptide.

Grass Pollen Allergy Drugs Market, by Targets

Grass Pollen Allergy Drugs Market, by Targets

For more target insights, download a free report sample

Key MoA in the Grass Pollen Allergy Pipeline Drugs Market

The key mechanisms of action in the Grass Pollen Allergy pipeline drugs market are Interleukin 4 Receptor Subunit Alpha Antagonist, and Pituitary Adenylate Cyclase Activating Polypeptide Inhibitor.

Grass Pollen Allergy Pipeline Drugs Market, by MoA

Grass Pollen Allergy Pipeline Drugs Market, by MoA

To get more insights on key MoA, download a free sample report

Grass Pollen Allergy Pipeline Drugs Market Segmentation by RoA

The key routes of administration in the Grass Pollen Allergy pipeline drugs market are Subcutaneous, Intravenous, Oral, and Sublingual.

Grass Pollen Allergy Pipeline Drugs Market Analysis, by RoA

Grass Pollen Allergy Pipeline Drugs Market Analysis, by RoA

To get more insights on key RoA, download a free sample report

Key Molecule Types in the Grass Pollen Allergy Pipeline Drugs Market

The key molecule types in the Grass Pollen Allergy pipeline drugs market are Allergenics (Allergen), Monoclonal Antibody, Conjugate Vaccine, Peptide, Synthetic Peptide, and Vaccine.

Grass Pollen Allergy Pipeline Drugs Market, by Molecule Type

Grass Pollen Allergy Pipeline Drugs Market, by Molecule Type

To get more insights on key molecule types, download a free sample report

Major Companies in the Grass Pollen Allergy Pipeline Drugs Market

The major companies in the Grass Pollen Allergy pipeline drugs market are Allergy Therapeutics Plc, ASIT Biotech SA, DC4U BV, H. Lundbeck AS, HAL Allergy BV, Regeneron Pharmaceuticals Inc, Revolo Biotherapeutics Ltd, Roxall Medizin GmbH, and Worg Pharmaceuticals Hangzhou Co Ltd.

Grass Pollen Allergy Pipeline Drugs Market, by Major Companies

Grass Pollen Allergy Pipeline Drugs Market, by Major Companies

For more company insights, download a free sample report

Grass Pollen Allergy Pipeline Drugs Market Overview

Key Targets Interleukin 4 Receptor Subunit Alpha, and Pituitary Adenylate Cyclase Activating Polypeptide
Key Mechanisms of action Interleukin 4 Receptor Subunit Alpha Antagonist, and Pituitary Adenylate Cyclase Activating Polypeptide Inhibitor
Key Routes of Administration Subcutaneous, Intravenous, Oral, and Sublingual
Key Molecule Types Allergenics (Allergen), Monoclonal Antibody, Conjugate Vaccine, Peptide, Synthetic Peptide, and Vaccine
Major Companies Allergy Therapeutics Plc, ASIT Biotech SA, DC4U BV, H. Lundbeck AS, HAL Allergy BV, Regeneron Pharmaceuticals Inc, Revolo Biotherapeutics Ltd, Roxall Medizin GmbH, and Worg Pharmaceuticals Hangzhou Co Ltd

Scope

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Grass Pollen Allergy
  • The pipeline guide reviews pipeline therapeutics for Grass Pollen Allergy by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Grass Pollen Allergy therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Grass Pollen Allergy therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews the latest news related to pipeline therapeutics for Grass Pollen Allergy

Reasons to Buy

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with a potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Grass Pollen Allergy
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Grass Pollen Allergy pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.

Allergy Therapeutics Plc
ASIT Biotech SA
DC4U BV
H. Lundbeck AS
HAL Allergy BV
Regeneron Pharmaceuticals Inc
Revolo Biotherapeutics Ltd
Roxall Medizin GmbH
Worg Pharmaceuticals Hangzhou Co Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Introduction

Global Markets Direct Report Coverage

Grass Pollen Allergy – Overview

Grass Pollen Allergy – Therapeutics Development

Pipeline Overview

Pipeline by Companies

Products under Development by Companies

Grass Pollen Allergy – Therapeutics Assessment

Assessment by Target

Assessment by Mechanism of Action

Assessment by Route of Administration

Assessment by Molecule Type

Grass Pollen Allergy – Companies Involved in Therapeutics Development

Allergy Therapeutics Plc

ASIT Biotech SA

DC4U BV

H. Lundbeck AS

HAL Allergy BV

Regeneron Pharmaceuticals Inc

Revolo Biotherapeutics Ltd

Roxall Medizin GmbH

Worg Pharmaceuticals Hangzhou Co Ltd

Grass Pollen Allergy – Drug Profiles

Allergen for Grass Pollen Allergy – Drug Profile

Product Description

Mechanism Of Action

Allergen for Pollen Grass Allergy Induced Allergic Rhinitis and Rhinoconjunctivitis – Drug Profile

Product Description

Mechanism Of Action

History of Events

dupilumab – Drug Profile

Product Description

Mechanism Of Action

History of Events

gp-ASIT – Drug Profile

Product Description

Mechanism Of Action

History of Events

IRL-201104 – Drug Profile

Product Description

Mechanism Of Action

LuAG-09222 – Drug Profile

Product Description

Mechanism Of Action

History of Events

Pollinex Quattro Grass – Drug Profile

Product Description

Mechanism Of Action

History of Events

Vaccine for Grass Pollen Allergy – Drug Profile

Product Description

Mechanism Of Action

Vaccine for Grass Pollen Allergy and House Dust Mite Allergy – Drug Profile

Product Description

Mechanism Of Action

WP-1048 – Drug Profile

Product Description

Mechanism Of Action

History of Events

Grass Pollen Allergy – Dormant Projects

Grass Pollen Allergy – Discontinued Products

Grass Pollen Allergy – Product Development Milestones

Featured News & Press Releases

May 06, 2021: Allergy Therapeutics: Completion of treatment phase in G309 study

Aug 26, 2020: Chronic hepatitis B: vaccine against grass pollen allergy as potential treatment

Nov 26, 2019: Allergy Therapeutics announces update to Grass MATA MPL phase III clinical programme

Jun 27, 2019: Allergy Therapeutics: Successful litigation settlement relating to PQ Grass Phase II Trial

Apr 25, 2019: Allergy Therapeutics provides regulatory and trading update

Jun 25, 2018: Allergy Therapeutics announces publication of data demonstrating long-lasting efficacy of Pollinex Quattro Grass vaccine in Immunotherapy

May 21, 2018: Allergy Therapeutics announces positive top-line results from its Grass MATA MPL Phase II dose ranging study

Feb 05, 2018: Landmark clinical study with grass pollen vaccine BM32 published

Jan 26, 2017: Biomay AG Reports Positive Results From A Second Phase IIb Trial With The Innovative 3rd Generation Grass Pollen Allergy Vaccine BM32

Sep 08, 2016: Grass pollen allergy vaccine also effective against hepatitis B

Jun 27, 2016: Allergy Therapeutics announces findings from mEEC dose range finding study G204

Mar 04, 2016: Inflamax Research Announces the Successful Completion of Enrollment for the First Multi-center, Mobile Environmental Exposure Chamber (mEEC) Study

Feb 18, 2016: Allergy Therapeutics Announces Patient enrolment completed in US Phase IIb study of GrassMATAMPL

Jan 28, 2016: Biomay initiates new phase II clinical trial with grass pollen allergy vaccine BM32

Jun 03, 2015: Positive phase IIb data on BM32, Biomay’s innovative grass pollen allergy vaccine will be reported in hot topic session at major international scientific conference.

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

Table

List of Tables

Number of Products under Development for Grass Pollen Allergy, 2022

Number of Products under Development by Companies, 2022

Products under Development by Companies, 2022

Number of Products by Stage and Target, 2022

Number of Products by Stage and Mechanism of Action, 2022

Number of Products by Stage and Route of Administration, 2022

Number of Products by Stage and Molecule Type, 2022

Grass Pollen Allergy – Pipeline by Allergy Therapeutics Plc, 2022

Grass Pollen Allergy – Pipeline by ASIT Biotech SA, 2022

Grass Pollen Allergy – Pipeline by DC4U BV, 2022

Grass Pollen Allergy – Pipeline by H. Lundbeck AS, 2022

Grass Pollen Allergy – Pipeline by HAL Allergy BV, 2022

Grass Pollen Allergy – Pipeline by Regeneron Pharmaceuticals Inc, 2022

Grass Pollen Allergy – Pipeline by Revolo Biotherapeutics Ltd, 2022

Grass Pollen Allergy – Pipeline by Roxall Medizin GmbH, 2022

Grass Pollen Allergy – Pipeline by Worg Pharmaceuticals Hangzhou Co Ltd, 2022

Grass Pollen Allergy – Dormant Projects, 2022

Grass Pollen Allergy – Discontinued Products, 2022

Figures

List of Figures

Number of Products under Development for Grass Pollen Allergy, 2022

Number of Products under Development by Companies, 2022

Number of Products by Targets, 2022

Number of Products by Stage and Targets, 2022

Number of Products by Top 10 Mechanism of Actions, 2022

Number of Products by Stage and Top 10 Mechanism of Actions, 2022

Number of Products by Routes of Administration, 2022

Number of Products by Stage and Routes of Administration, 2022

Number of Products by Molecule Types, 2022

Number of Products by Stage and Top 10 Molecule Types, 2022

Frequently asked questions

Grass Pollen Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update thematic reports
Currency USD
$2,000

Can be used by individual purchaser only

$6,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Grass Pollen Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update in real time.

  • Access a live Grass Pollen Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.